ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications - Top-Institutions - MDSpire

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • By

  • Torsten Kucharzik

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stuart Taylor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mariangela Allocca

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Johan Burisch

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pierre Ellul

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Marietta Iacucci

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Christian Maaser

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pamela Baldin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Gauraang Bhatnagar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Shomron Ben-Horin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Dominik Bettenworth

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mallory Chavannes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Ann Driessen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Emma Flanagan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Frederica Furfaro

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Giovanni Maconi

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstaninos Karmiris

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Amelia Kellar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Isabelle De Kock

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstantinos Katsanos

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Uri Kopylov

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Cathy Lu

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Olga Maria Nardone

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nurulamin M Noor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Kerri Novak

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Paula Borralho Nunes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Patrick van Rheenen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jordi Rimola

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Francesca Rosini

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • David Rubin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Martina Scharitzer

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jaap Stoker

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mathieu Uzzan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stephan Vavricka

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Bram Verstockt

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Rune Wilkens

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nina Zidar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Alessandra Zilli

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Henit Yanai

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Roger Feakins

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Radiology
    • Pathology

  • #2

    Mount Sinai Hospital
    Mount Sinai Hospital

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Radiology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Radiology
    • Pathology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Radiology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Radiology
    • Pathology

Original Source(s)

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • by Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Isabelle De Kock, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), David Rubin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

Related Content

Progression of Coronary Calcium Detected on Routine Chest CT Enhances Cardiovascular Risk Assessment in Individuals with Inflammatory Bowel Disease: Findings from a Multicenter Study

REACHing forward—a strategic vision for ECCO and the future of IBD care

Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation